CD160 Expression in Retinal Vessels Is Associated With Retinal Neovascular Diseases | Zendy

Adrien Henry | Zendy; Camille BoulagRombi | Zendy; Thierry Menguy | Zendy; Jérôme Giustiniani | Zendy; Christian Garbar | Zendy; Corinne Mascaux | Zendy; Marc Labrousse | Zendy; Corentin Milas | Zendy; Coralie Barbe | Zendy; Armand Bensussan | Zendy; Vincent Durlach | Zendy; Carl Arndt | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

CD160 Expression in Retinal Vessels Is Associated With Retinal Neovascular Diseases

Author(s) -

Adrien Henry,

Camille BoulagRombi,

Thierry Menguy,

Jérôme Giustiniani,

Christian Garbar,

Corinne Mascaux,

Marc Labrousse,

Corentin Milas,

Coralie Barbe,

Armand Bensussan,

Vincent Durlach,

Carl Arndt

Publication year - 2018

Publication title -

investigative ophthalmology and visual science

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.935

H-Index - 218

eISSN - 1552-5783

pISSN - 0146-0404

DOI - 10.1167/iovs.18-24021

Subject(s) - retinal , pathology , retina , endothelial stem cell , medicine , endothelium , biology , ophthalmology , biochemistry , neuroscience , in vitro

Anti-angiogenic agents stand first in the treatment of neovascular diseases of the retina. CD160 appeared in several experimental studies as a marker of activated endothelial cells, suggesting it could represent a promising target for novel anti-angiogenic therapies. The aim of the present study was to assess the distribution of CD160 in the human eye, and to search for a possible correlation with retinal neovascular diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research